Clinical Trial Update: Influence of MMP on Brain AVM Hemorrhage [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the role of matrix metalloproteinases (MMP) in brain arteriovenous malformation hemorrhage; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arteriovenous Malformations
• Cerebral Cavernous Malformations
• Intracranial Aneurysms

Snippet

Sponsor: University of California, San Francisco | Conditions: Arteriovenous Malformations, Cavernous Angiomas | Phase 1 | Status: COMPLETED